NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Clinical trial NCT05252390 · TERMINATED
Trial details
- NCT number
- NCT05252390
- Sponsor
- Nuvation Bio Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2024-07-15
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.